Lifeward Ltd.

As of June 30, 2026, Lifeward Ltd. carries a market capitalization of 21.67M, placing it among publicly traded companies globally. Its enterprise value stands at 19.21M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Lifeward Ltd.'s next confirmed earnings release is scheduled for November 17, 2026.

As of June 30, 2026, Lifeward Ltd. has 2.83M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 0.63, and the price-to-book ratio stands at 1.77.

These figures are as of June 30, 2026. The EV/Sales ratio of 0.88 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 19.21M versus a market cap of 21.67M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Lifeward Ltd. maintains a current ratio of 2.33, meaning it holds 2.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 57.20, indicating elevated leverage, while an interest coverage ratio of -13.55 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Lifeward Ltd. posted a negative return on equity (ROE) of -225.65, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -99.81, reflecting losses generated across the asset base. The company generates approximately 270,241.49 in revenue per employee across its workforce of 80.75, a quick read on workforce productivity versus industry peers. Inventory turnover of 2.03 indicates how many times Lifeward Ltd. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Lifeward Ltd. recorded an income tax benefit of -50,000.00 rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -30.88M and -30.83M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on November 4, 2026, Lifeward Ltd.'s stock has declined approximately 8.76% over the past 52 weeks. The 50-day moving average sits at 6.58, while the 200-day moving average is 6.93.

Over the twelve months ended June 30, 2026, Lifeward Ltd. generated 21.82M in revenue and converted that into -30.83M in net income, yielding earnings per share of -17.06. EBITDA reached -17.43M, while operating income came in at -22.75M.

As of June 30, 2026, Lifeward Ltd. holds 9.45M in cash and equivalents against 6.99M in total debt, resulting in a net debt position of -5.02M. Total book value stands at 12.22M, with working capital of 14.79M providing operational flexibility.

Lifeward Ltd. produced -17.08M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -19,000.00 in capital expenditures, free cash flow totaled -17.10M - equivalent to -9.46 per share.

Over the twelve months ended June 30, 2026, Lifeward Ltd. posted a gross margin of 35.95, reflecting its pricing power and cost economics. The operating margin of -104.25 and net profit margin of -141.28 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -123.47: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -68.91, meaning Lifeward Ltd. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Lifeward Ltd.'s most recent stock split took place on February 24, 2026 with a 12:1 split ratio.

As of June 30, 2026, Lifeward Ltd. has an Altman Z-Score of -15.04, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.